VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed […]
Fourth Quarter Results In-Line with Previously Announced Expectations Plate and Strip Operations Running at Planned Production Levels Reaffirmed Outlook on […]